APO Research
Talk to an analyst

APO RESEARCH · REPORT

Measle Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Measle Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025175 pages

Choose your research edition.

Industry ResearchMeasle Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Measle Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Measle Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Measle Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Measle Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Measle Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Measle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Measle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Measle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Measle Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Measle Vaccine include Merck, McKesson Medical and Biovac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Measle Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Measle Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Measle Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Measle Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Measle Vaccine Segment by Company

Merck

McKesson Medical

Biovac

Measle Vaccine Segment by Type

Inactivated Vaccine

Attenuated Vaccine

Measle Vaccine Segment by Application

Hospital

Scientific Research

Others

Measle Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Measle Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Measle Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Measle Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Measle Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Measle Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Measle Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Measle Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Measle Vaccine Industry Trends Table 2. Measle Vaccine Industry Drivers Table 3. Measle Vaccine Industry Opportunities and Challenges Table 4. Measle Vaccine Industry Restraints Table 5. Global Measle Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Measle Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Measle Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Measle Vaccine Sales Market Share by Manufacturers Table 9. Global Measle Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Measle Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Measle Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Measle Vaccine Manufacturers, Product Type & Application Table 13. Global Measle Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Measle Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Vaccine Table 17. Major Manufacturers of Attenuated Vaccine Table 18. Global Measle Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Measle Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Measle Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Measle Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Measle Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Measle Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Measle Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Measle Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Scientific Research Table 30. Major Manufacturers of Others Table 31. Global Measle Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Measle Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Measle Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Measle Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Measle Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Measle Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Measle Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Measle Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Measle Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Measle Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Measle Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Measle Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Measle Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Measle Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Measle Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Measle Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Measle Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Measle Vaccine Revenue Market Share by Region (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Measle Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Measle Vaccine Product Portfolio Table 67. Merck Recent Development Table 68. McKesson Medical Company Information Table 69. McKesson Medical Business Overview Table 70. McKesson Medical Measle Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. McKesson Medical Measle Vaccine Product Portfolio Table 72. McKesson Medical Recent Development Table 73. Biovac Company Information Table 74. Biovac Business Overview Table 75. Biovac Measle Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biovac Measle Vaccine Product Portfolio Table 77. Biovac Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Measle Vaccine Distributors List Table 81. Measle Vaccine Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Measle Vaccine Product Image Figure 2. Global Measle Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Measle Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Measle Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Measle Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Measle Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Vaccine Image Figure 9. Attenuated Vaccine Image Figure 10. Global Measle Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Measle Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Measle Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Measle Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Measle Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Measle Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Scientific Research Image Figure 18. Others Image Figure 19. Global Measle Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Measle Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Measle Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Measle Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Measle Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Measle Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Measle Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Measle Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Measle Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Measle Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Measle Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Measle Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Measle Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Measle Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Measle Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Measle Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Measle Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Measle Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Measle Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Attenuated Vaccine
Applications
  • Hospital
  • Scientific Research
  • Others
Companies covered
  • Merck
  • McKesson Medical
  • Biovac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Measle Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Measle Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Measle Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Measle Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Measle Vaccine Market Dynamics
  1. 2.1 Measle Vaccine Industry Trends
  2. 2.2 Measle Vaccine Industry Drivers
  3. 2.3 Measle Vaccine Industry Opportunities and Challenges
  4. 2.4 Measle Vaccine Industry Restraints
3 Measle Vaccine Market by Manufacturers
  1. 3.1 Global Measle Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Measle Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Measle Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Measle Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Measle Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Measle Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Measle Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Measle Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Measle Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Measle Vaccine Tier 1, Tier 2, and Tier 3
4 Measle Vaccine Market by Type
  1. 4.1 Measle Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Attenuated Vaccine
  4. 4.2 Global Measle Vaccine Sales by Type
  5. 4.2.1 Global Measle Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Measle Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Measle Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Measle Vaccine Revenue by Type
  9. 4.3.1 Global Measle Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Measle Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Measle Vaccine Revenue Market Share by Type (2021-2032)
5 Measle Vaccine Market by Application
  1. 5.1 Measle Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Measle Vaccine Sales by Application
  6. 5.2.1 Global Measle Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Measle Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Measle Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Measle Vaccine Revenue by Application
  10. 5.3.1 Global Measle Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Measle Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Measle Vaccine Revenue Market Share by Application (2021-2032)
6 Global Measle Vaccine Sales by Region
  1. 6.1 Global Measle Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Measle Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Measle Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Measle Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Measle Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Measle Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Measle Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Measle Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Measle Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Measle Vaccine Revenue by Region
  1. 7.1 Global Measle Vaccine Revenue by Region
  2. 7.1.1 Global Measle Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Measle Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Measle Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Measle Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Measle Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Measle Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Measle Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Measle Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Measle Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Measle Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Measle Vaccine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 McKesson Medical
  8. 8.2.1 McKesson Medical Company Information
  9. 8.2.2 McKesson Medical Business Overview
  10. 8.2.3 McKesson Medical Measle Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 McKesson Medical Measle Vaccine Product Portfolio
  12. 8.2.5 McKesson Medical Recent Developments
  13. 8.3 Biovac
  14. 8.3.1 Biovac Company Information
  15. 8.3.2 Biovac Business Overview
  16. 8.3.3 Biovac Measle Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biovac Measle Vaccine Product Portfolio
  18. 8.3.5 Biovac Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Measle Vaccine Value Chain Analysis
  2. 9.1.1 Measle Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Measle Vaccine Production Mode & Process
  6. 9.2 Measle Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Measle Vaccine Distributors
  9. 9.2.3 Measle Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst